System Transmission

Top Signal

100#1 JOB

Activity

2179Ripe

+938 today

System

Live1m

Terminal Asset View

stockNASDAQ

ABUS

$4.26-1.39%

Arbutus Biopharma Corporation - Common Stock

Neutral

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

17Neutral

Live Analysis Active

Company Mission

Arbutus Biopharma is a biotechnology company that researches and develops medicines to treat viral infections. They focus on creating treatments for diseases like hepatitis B and COVID-19 by designing drugs that target the viruses directly. The company makes money through partnerships with larger pharmaceutical companies, licensing its technology to them, and receiving payments for research and development milestones.

ABU

Industry Context

The biotech industry focuses on developing new medical treatments using biological science. Companies in this space often have high research costs and long development timelines, but successful treatments can be very valuable. Investors watch for clinical trial results, regulatory approvals, and partnership deals as key drivers of stock performance.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

15Matrix

Market Momentum

75.9— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

-1.39%— Live Performance

Social Frequency

Listening

Social Freq

0.2x

Normal Vol

X/Twitter Activity

0.2x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

13Velocity

Live Sync

Social Intelligence Pulse.

Our engine is currently indexing ABUS across global social channels to detect early sentiment shifts and technical alignment.

XActive

RedditActive

WebActive

Social Growth+3.0% vs 7D

Signal CoverageStandard Coverage

Signal Catalysts

Intelligence Narrative Connected

Updated 12:40 AM UTC

As-of 03-15-2026 00:24 UTC

Develops medicines that treat viral infections and makes money by licensing its drug discoveries to larger pharmaceutical companies.

Monthly chart shows base formation near $4, suggesting a strong foundation for potential moves as buyers and sellers find balance showing showing.

Biotech sector showing renewed interest as investors seek innovative treatments, benefiting companies with promising clinical-stage pipelines, suggesting clinical-stage pipelines.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...